Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
0.180
+0.001 (0.67%)
At close: Dec 27, 2024, 4:00 PM
0.181
+0.001 (0.28%)
After-hours: Dec 27, 2024, 7:49 PM EST
Applied DNA Sciences Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
Cash & Equivalents | 6.43 | 6.43 | 7.15 | 15.22 | 6.55 | 7.79 | Upgrade
|
Cash & Short-Term Investments | 6.43 | 6.43 | 7.15 | 15.22 | 6.55 | 7.79 | Upgrade
|
Cash Growth | -10.08% | -10.08% | -53.00% | 132.12% | -15.82% | 1293.01% | Upgrade
|
Receivables | 0.36 | 0.36 | 0.26 | 3.07 | 2.8 | 0.19 | Upgrade
|
Inventory | 0.44 | 0.44 | 0.33 | 0.6 | 1.37 | 0.5 | Upgrade
|
Prepaid Expenses | 0.82 | 0.82 | 0.39 | 1.06 | 0.57 | 0.6 | Upgrade
|
Total Current Assets | 8.05 | 8.05 | 8.13 | 19.94 | 11.3 | 9.08 | Upgrade
|
Property, Plant & Equipment | 1.29 | 1.29 | 2.08 | 2.22 | 3.02 | 1.28 | Upgrade
|
Goodwill | - | - | - | - | - | 0.29 | Upgrade
|
Other Intangible Assets | 2.7 | 2.7 | 2.7 | - | - | 0.61 | Upgrade
|
Other Long-Term Assets | 0.75 | 0.75 | 0.75 | 0.1 | 0.1 | 0.1 | Upgrade
|
Total Assets | 12.79 | 12.79 | 13.65 | 22.27 | 14.42 | 11.34 | Upgrade
|
Accounts Payable | 1.17 | 1.17 | 1.07 | 1.74 | 2.01 | 1.25 | Upgrade
|
Accrued Expenses | 0.63 | 0.63 | 1.2 | 1.88 | 0.98 | 0.68 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | - | 1.83 | Upgrade
|
Current Portion of Leases | 0.55 | 0.55 | 0.5 | - | - | - | Upgrade
|
Current Unearned Revenue | 0.06 | 0.06 | 0.08 | 0.56 | 0.28 | 0.51 | Upgrade
|
Total Current Liabilities | 2.4 | 2.4 | 2.85 | 4.19 | 3.27 | 4.27 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 0.52 | Upgrade
|
Long-Term Leases | 0.19 | 0.19 | 0.74 | - | - | - | Upgrade
|
Long-Term Unearned Revenue | 0.19 | 0.19 | 0.19 | - | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.68 | 0.68 | 0.68 | - | - | - | Upgrade
|
Other Long-Term Liabilities | 0.35 | 0.35 | 4.32 | 5.17 | 0.03 | 0.85 | Upgrade
|
Total Liabilities | 3.82 | 3.82 | 8.78 | 9.36 | 3.3 | 5.63 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 318.81 | 318.81 | 307.4 | 305.4 | 295.23 | 275.55 | Upgrade
|
Retained Earnings | -309.67 | -309.67 | -302.45 | -292.5 | -284.12 | -269.84 | Upgrade
|
Total Common Equity | 9.14 | 9.14 | 4.95 | 12.91 | 11.11 | 5.72 | Upgrade
|
Minority Interest | -0.17 | -0.17 | -0.08 | -0 | -0 | -0.01 | Upgrade
|
Shareholders' Equity | 8.97 | 8.97 | 4.87 | 12.91 | 11.11 | 5.71 | Upgrade
|
Total Liabilities & Equity | 12.79 | 12.79 | 13.65 | 22.27 | 14.42 | 11.34 | Upgrade
|
Total Debt | 0.74 | 0.74 | 1.24 | - | - | 2.35 | Upgrade
|
Net Cash (Debt) | 5.69 | 5.69 | 5.91 | 15.22 | 6.55 | 5.44 | Upgrade
|
Net Cash Growth | -3.76% | -3.76% | -61.13% | 132.12% | 20.48% | - | Upgrade
|
Net Cash Per Share | 1.44 | 1.44 | 9.05 | 33.93 | 18.95 | 27.77 | Upgrade
|
Filing Date Shares Outstanding | 52.29 | 52.29 | 0.68 | 0.65 | 0.37 | 0.28 | Upgrade
|
Total Common Shares Outstanding | 10.31 | 10.31 | 0.68 | 0.65 | 0.37 | 0.26 | Upgrade
|
Working Capital | 5.65 | 5.65 | 5.28 | 15.76 | 8.03 | 4.81 | Upgrade
|
Book Value Per Share | 0.89 | 0.89 | 7.25 | 20.01 | 29.69 | 22.24 | Upgrade
|
Tangible Book Value | 6.44 | 6.44 | 2.25 | 12.91 | 11.11 | 4.83 | Upgrade
|
Tangible Book Value Per Share | 0.62 | 0.62 | 3.30 | 20.01 | 29.69 | 18.77 | Upgrade
|
Machinery | 4.54 | 4.54 | 4.13 | 4.17 | 3.67 | 3.2 | Upgrade
|
Leasehold Improvements | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.